Lund University is celebrating 350 years. Read more on lunduniversity.lu.se

Menu

Javascript is not activated in your browser. This website needs javascript activated to work properly.
You are here

Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: rationale and design of the epidemiological studies within the IMI DIRECT Consortium.

Author:
  • Robert Koivula
  • Alison Heggie
  • Anna Barnett
  • Henna Cederberg
  • Tue H Hansen
  • Anitra D Koopman
  • Martin Ridderstråle
  • Femke Rutters
  • Henrik Vestergaard
  • Ramneek Gupta
  • Sanna Herrgård
  • Martijn W Heymans
  • Mandy H Perry
  • Simone Rauh
  • Maritta Siloaho
  • Harriet J A Teare
  • Barbara Thorand
  • Jimmy Bell
  • Søren Brunak
  • Gary Frost
  • Bernd Jablonka
  • Andrea Mari
  • Tim J McDonald
  • Jacqueline M Dekker
  • Torben Hansen
  • Andrew Hattersley
  • Markku Laakso
  • Oluf Pedersen
  • Veikko Koivisto
  • Hartmut Ruetten
  • Mark Walker
  • Ewan Pearson
  • Paul Franks
Publishing year: 2014
Language: English
Pages: 1132-1142
Publication/Series: Diabetologia
Volume: 57
Issue: 6
Document type: Journal article
Publisher: Springer Verlag

Abstract english

The DIRECT (Diabetes Research on Patient Stratification) Study is part of a European Union Framework 7 Innovative Medicines Initiative project, a joint undertaking between four industry and 21 academic partners throughout Europe. The Consortium aims to discover and validate biomarkers that: (1) predict the rate of glycaemic deterioration before and after type 2 diabetes onset; (2) predict the response to diabetes therapies; and (3) help stratify type 2 diabetes into clearly definable disease subclasses that can be treated more effectively than without stratification. This paper describes two new prospective cohort studies conducted as part of DIRECT.

Keywords

  • Endocrinology and Diabetes

Other

Published
  • Genetic and Molecular Epidemiology
  • Clinical Obesity
  • ISSN: 1432-0428
Paul Franks
E-mail: paul.franks [at] med.lu.se

Principal investigator

Genetic and Molecular Epidemiology

+46 40 39 11 49

60-12-021

33

Lund University Diabetes Centre, CRC, SUS Malmö, Entrance 72, House 91:12. SE-205 02 Malmö. Telephone: +46 40 39 10 00